Nephrology News

A study of patients on hemodialysis found potassium levels that deviate outside of the target range may be a more accurate predictor of hyperkalemic events than a single measurement or time-averaged values.

After estimating levels of fine particulate matter air pollution, researchers from China found neighborhoods with more pollution had an increased prevalence of chronic kidney disease and albuminuria.

The FDA has approved belimumab in intravenous and subcutaneous formulations for the treatment of lupus nephritis in adult patients who are receiving standard therapy, according to a press release from GlaxoSmithKline.

An analysis of data from the United Network for Organ Sharing suggests the COVID-19 pandemic has had a significant impact on transplantation in the United States, especially in the initial months.

A published study found kidney biopsies performed in the United States did not accurately predict allograft survival or overall organ quality.

Legislation that offers lifetime immunosuppressive drug coverage for Medicare patients who receive a kidney transplant regardless of age has passed the U.S. House of Representatives.

Study findings show Black men who receive hemodialysis in communities with a higher proportion of Black residents experience worse outcomes than those who receive treatments in communities with fewer Black residents.

Accountable care organizations generated modest savings in the care of Medicare beneficiaries undergoing dialysis when patients received routine care from primary care physicians.

The National Renal Administrators Association sent letters to CMS and the CDC urging the agencies to prioritize issuance of the COVID-19 vaccine to patients with end-stage renal disease and the dialysis clinic staff who provide their care.

Despite finding patients and providers have “positive perceptions” of nutrition therapy in chronic kidney disease, researchers suggest the broad implementation of such programs may be limited due to cost-related factors.